Primary Diffuse Large B-cell Lymphoma of the Urinary Bladder: A Case Report and Narrative Review of Treatment Modalities and Clinical Outcomes. (PubMed, Cureus) - Oct 1, 2026 - "Given her frailty and comorbidities, she was treated with rituximab monotherapy followed by involved-site radiotherapy instead of anthracycline-based chemoimmunotherapy, achieving marked metabolic and anatomic regression of the bladder lesion on positron emission tomography (PET)/CT. We present a narrative review of the literature on primary bladder DLBCL, highlight diagnostic and therapeutic considerations in the context of severe frailty, and discuss how de-escalated, organ-preserving strategies may be appropriate for selected patients."
Journal • B Cell Lymphoma • Bladder Cancer • Diffuse Large B Cell Lymphoma • Geriatric Disorders • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Multiple Myeloma • Nephrology • Non-Hodgkin's Lymphoma • Oncology • Pain • Solid Tumor • BCL2 • BCL6 • CD20 • CD5 • LXN • MME
|
|
Brian Stisser; Christopher J Wenzinger; Kelvin B Raybon; Ramyar M Abdullah
|